Insider Monkey: 10 small-cap consumer staples names under $30

Since the start of the year, the S&P 500 Consumer Discretionary index has declined 8.5%. By comparison, the S&P 500 Energy index has surged nearly 32%. Meanwhile, at the beginning of the year, the consumer segment was viewed by investors as a “refuge” amid overheating Big Tech stocks.

Not all consumer-segment players are under pressure. however, and Insider Monkey has selected 10 of the most promising small caps in the segment with strong upside. The list includes companies with market capitalizations between $300 million and $2 billion, listed in the U.S., with share prices below $30.

The company manufactures and distributes dietary supplements for health and wellness, as well as personal care products, through a multi-level marketing model. Its portfolio includes products for bone, cellular, and joint health, cognitive function, sleep and energy support, and blood sugar management.

On March 11, Nature’s Sunshine reported fourth-quarter results: revenue increased 4.7% year over year to $123.8 million, while adjusted EBITDA rose 16% to $11.9 million. CEO Ken Romanci said that full-year sales, which grew 5% to $480.1 million, marked an all-time high for the company.

Following the results, DA Davidson raised its target price on Nature’s Sunshine Products from $23 per share to $33 per share, maintaining a “buy” rating. Analysts said that the company continues to outperform expectations, with further growth potential supported by expansion into new markets and the development of digital sales.

According to MarketWatch data, the company has two analyst ratings, both “buy.” With a target price of $33 per share, the shares have nearly 35% upside from the closing price on Wednesday.

The company specializes in the production and distribution of frozen foods. Nomad Foods has a strong presence in Europe and owns a number of local brands.

In the fourth quarter, Nomad Foods’ revenue declined 2.6% to EUR773.1 million, while adjusted EBITDA fell 4.7% to EUR131 million. The company stated that the decline in organic revenue slowed in the fourth quarter, while retail sales growth accelerated.

Following the report, on March 2, BTIG lowered its target price from $18 per share to $15 per share, maintaining a “buy” rating. The firm cited weak performance, continued declines in organic sales volumes, and inflationary pressure.

Wall Street remains optimistic: seven analysts recommend buying Nomad Foods shares (four “buy” ratings and two “overweight”), while one rates the stock “hold.” The average target price is $11.60 per share, implying more than 20% upside.

The discount retailer of groceries and everyday goods maintains low prices through its purchasing model, acquiring excess inventory, repackaged goods, and surplus stock.

In the fourth quarter, Grocery Outlet’s net revenue increased 10.7% year over year to $1.22 billion. The company stated that growth was driven by sales from new stores, partially offset by a 0.8% decline in comparable sales due to a 1.7% drop in average ticket size. Adjusted net income for the quarter was $18.7 million ($0.19 per share) versus $14.5 million ($0.15 per share) a year earlier.

On March 9, BofA Securities lowered its target price on Grocery Outlet from $13 per share to $10.5 per share, maintaining a “neutral” rating. Analysts said this reflected uncertainty around the timing of a recovery in comparable sales and average ticket.

According to MarketWatch data, the company has 14 “hold” ratings, one “buy,” and one “sell.” The average target price is $7.86 per share, implying 14% upside.

The company specializes in the production of coffee and coffee-based beverages, as well as tea, flavors, extracts, and energy drinks.

Westrock Coffee reported a 48.3% increase in fourth-quarter revenue to $339.5 million. The net loss narrowed 8% to $22.6 million. CEO and cofounder Scott Ford said that, following the launch of the Conway extracts and ready-to-drink facility, the company will focus on driving sales growth, optimizing its product mix, and improving profitability.

Following the report, Stifel lowered its target price on Westrock Coffee from $10 per share to $7 per share, maintaining a “buy” rating. Analysts see significant EBITDA growth potential through 2027 – approximately 35% on a two-year CAGR basis – along with balance sheet improvement.

The company has four Wall Street analyst ratings, all “buy.” The average target price is $7 per share, implying 64% upside.

The online learning platform partners with universities and educational institutions.

In early March, at a Morgan Stanley conference, Coursera stated that the acquisition and integration of Udemy would allow the combined company to reach a strategic revenue target of $1.5 billion. In addition, the merger is expected to generate $115 million in annual cost savings. Fourth-quarter revenue increased 10% year over year to $197 million, while the net loss widened 24% to $26.8 million. Full-year revenue rose 9% to $757 million.

Following the fourth-quarter report, KeyBanc lowered its target price from $12 per share to $10 per share, maintaining an “overweight” rating. Analysts said the move reflected a roughly 53% decline in Coursera’s share price over the last six months. However, KeyBanc continues to see long-term potential in the company’s enterprise segment and views the pending merger with Udemy positively.

Eight of 12 Wall Street analysts rate Coursera shares a “buy,” three “hold,” and one “sell.” The average target price is $9.70 per share, implying 65% upside.

The education company offers courses on its platform in technology, business, soft skills, and personal development. In March, the company introduced an agentic AI-based solution, Altus, designed to help identify key skills, train employees in the flow of work, and improve business outcomes. A full launch is expected in the second half of 2026.

Udemy’s fourth-quarter revenue declined 3% year over year to $194 million. The net loss totaled $2.3 million – 76% lower than a year earlier.

On February 6, Canaccord Genuity lowered its target price on Udemy from $7 per share to $5 per share, maintaining a “hold” rating. Analysts said that revenue and profit for the fourth quarter slightly exceeded expectations. Canaccord also highlighted Udemy’s progress in working with enterprise clients, helping deliver more personalized learning solutions for organizations.

According to MarketWatch data, analyst views are evenly split: two recommend “buy” and two “hold.” With an average target price of $7.60 per share, the stock has 65% upside.

The company is a global producer and supplier of food ingredients, as well as distilled and branded spirits, including vodka, whiskey, gin, and bourbon.

On February 25, the company reported a 23% year over year decline in fourth-quarter consolidated sales to $138.3 million. Gross profit fell 35% to $48.3 million. The company recorded a quarterly net loss of $134.6 million versus a loss of nearly $42 million a year earlier, due to a one-off noncash adjustment of $152.6 million.

On February 27, TD Cowen lowered its target price from $24 per share to $22 per share, maintaining a “hold” rating. Analysts said that fourth-quarter results exceeded market expectations, but the management’s outlook for 2026 came in significantly below the consensus forecast.

According to MarketWatch data, the company has four “buy” ratings and one “hold.” The average target price is $28.80 per share, implying 57% upside.

The snack manufacturer began more than a century ago as a family business and now produces and sells a wide range of snack products.

In the fourth quarter, net sales increased 0.4% to $342.2 million. The net loss totaled $3.3 million versus net income of $2.1 million in the same period of 2024. At a recent Consumer Analyst Group of New York conference, the company said it plans to grow 2-3% faster, including through launching on-trend products, geographic expansion, and strengthening its presence in key regions.

On March 26, Barclays maintained a “buy” rating on Utz Brands with a target price of $12 per share. Overall, the company has eight “buy” ratings ("buy" and "overweight") and three “hold,” according to MarketWatch data. With an average target price of $13.30 per share, the stock has 72% upside.

The company develops and sells packaged foods, snacks, and beverages under various brands. In early March, the company launched protein bars and chips under the Quest brand together with basketball player Sophie Cunningham, who describes herself as a long-time fan of the brand.

In the first quarter of 2026, net sales declined 0.3% to $340.2 million, while net income fell nearly a third to $25.3 million.

On March 16, Jefferies reiterated a “buy” rating and a target price of $22 per share – 50% above the current level. Analysts said that the current valuation overlooks Quest’s position as a category leader and the portfolio’s strong exposure to the “protein megatrend.”

Wall Street is broadly optimistic on Simply Good Foods. Eight of 13 analysts recommend “buy” (six “buy” and two “overweight”), while five recommend “hold.” The average target price is $27.20 per share, implying 91.5% upside.

The company sells pasture-raised eggs and butter sourced from more than 600 family farms. Its products are distributed nationwide across retail chains and foodservice operators.

Vital Farms’ net revenue in the fourth quarter increased 28.7% year over year to $213.6 million. Adjusted EBITDA rose 53% to $29.2 million. The company stated that it continues to make steady progress toward its goal of reaching $2 billion in revenue by 2030.

Following the report, Telsey Advisory Group lowered its target price on Vital Farms from $50 per share to $35 per share, maintaining an “outperform” rating. The firm noted that fourth-quarter results and the 2026 outlook came in below market expectations, mainly due to short-term disruptions in the egg industry. Despite this, analysts said that Vital Farms has solid prospects over the next few years, supported by business expansion and increased production capacity.

According to MarketWatch data, 10 of 12 analysts recommend buying Vital Farms shares, while two recommend “hold.” The average target price is $34.45 per share, more than double the current share price.